Strata Wealth Advisors LLC Makes New $453,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Strata Wealth Advisors LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 889 shares of the healthcare conglomerate’s stock, valued at approximately $453,000.

A number of other hedge funds have also recently made changes to their positions in the business. Macroview Investment Management LLC boosted its position in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Delos Wealth Advisors LLC raised its position in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the period. True Wealth Design LLC purchased a new position in UnitedHealth Group in the 4th quarter worth about $31,000. Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group in the second quarter worth $31,000. Finally, Signature Resources Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on UNH. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Monday, September 16th. Royal Bank of Canada boosted their target price on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. TD Cowen lifted their price objective on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. HSBC raised their target price on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Finally, Wells Fargo & Company increased their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Stock Down 0.2 %

UNH opened at $573.67 on Tuesday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The stock has a market capitalization of $528.00 billion, a price-to-earnings ratio of 35.07, a PEG ratio of 1.64 and a beta of 0.58. The company has a fifty day moving average of $578.27 and a two-hundred day moving average of $521.81.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business earned $6.14 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.46%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Insider Buying and Selling at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.